SOLAZYME INC COM STK (DE)
SZYM
SZYM was delisted on the 10th of May, 2016.
108 hedge funds and large institutions have $86.4M invested in SOLAZYME INC COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
11% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 28
7% more funds holding
Funds holding: 101 → 108 (+7)
3% less capital invested
Capital invested by funds: $89M → $86.4M (-$2.58M)
92% less call options, than puts
Call options by funds: $419K | Put options by funds: $5.28M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$807K |
| 2 |
Invesco
Atlanta,
Georgia
|
+$457K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$399K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$395K |
| 5 |
D.E. Shaw & Co
New York
|
+$246K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$516K |
| 2 |
MC
Menta Capital
San Francisco,
California
|
-$284K |
| 3 |
CC
Cambrian Capital
San Francisco,
California
|
-$277K |
| 4 |
Lazard Asset Management
New York
|
-$190K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$158K |
SZYM Hedge Fund Activity: Q4 2015 in Review
108 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in SOLAZYME INC COM STK (DE) (SZYM) for Q4 2015, worth a combined $86.4M — down 2.9% from $89M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new SZYM positions and 6 closed out — a net gain of 7 holders — while 31 added to existing stakes and 28 trimmed.
The largest buyer was Vanguard Group, adding an estimated $807K. The largest seller was Goldman Sachs, cutting an estimated $516K.
- 108 institutional investors held SOLAZYME INC COM STK (DE) (SZYM) as of Q4 2015, up from 101 in Q3 2015.
- Funds reported $86.4M of SOLAZYME INC COM STK (DE) stock for Q4 2015, down 2.9% quarter-over-quarter.
- 13 funds opened new SOLAZYME INC COM STK (DE) positions in Q4 2015 and 6 closed out, a net change of +7 holders.
- The largest SOLAZYME INC COM STK (DE) buyer in Q4 2015 was Vanguard Group, an estimated $807K added.
- The largest SOLAZYME INC COM STK (DE) seller in Q4 2015 was Goldman Sachs, an estimated $516K sold.
Based on aggregated 13F filings for Q4 2015.